JOHNS HOPKINS UNIVERSITY
π³π¦Namibia
- Country
- π³π¦Namibia
- Ownership
- -
- Established
- 1876-01-01
- Employees
- 19.4K
- Market Cap
- -
- Website
- https://www.jhu.edu/
Endoscopic Gastric Mucosal Devitalization (GMD) as a Primary Obesity Therapy
Not Applicable
Completed
- Conditions
- ObesityObesity, MorbidBariatric Surgery CandidateObesity; Endocrine
- Interventions
- Procedure: Gastric mucosal devitalization
- First Posted Date
- 2018-05-16
- Last Posted Date
- 2019-09-24
- Lead Sponsor
- Johns Hopkins University
- Target Recruit Count
- 6
- Registration Number
- NCT03526263
- Locations
- πΊπΈ
Johns Hopkins Bayview Medical Center, Baltimore, Maryland, United States
The Center for Peripartum Optimization
Completed
- Conditions
- High Risk PregnancyObstetric ComplicationMultidisciplinary CommunicationCommunication
- Interventions
- Other: Seen in clinic
- First Posted Date
- 2018-05-11
- Last Posted Date
- 2021-09-13
- Lead Sponsor
- Johns Hopkins University
- Target Recruit Count
- 250
- Registration Number
- NCT03522909
- Locations
- πΊπΈ
Johns Hopkins Hospital, Baltimore, Maryland, United States
Buspirone for Opioid Tapering
Phase 1
Completed
- Conditions
- Dependency (Psychology)Opioid-Related DisordersPain, ChronicOpiate Withdrawal Syndrome
- Interventions
- Drug: Placebo oral capsule
- First Posted Date
- 2018-05-11
- Last Posted Date
- 2020-07-23
- Lead Sponsor
- Johns Hopkins University
- Target Recruit Count
- 18
- Registration Number
- NCT03521960
- Locations
- πΊπΈ
Johns Hopkins University, Baltimore, Maryland, United States
A Therapeutic Workplace to Address Poverty and Substance Use
Not Applicable
Completed
- Conditions
- Substance Use Disorders
- Interventions
- Behavioral: IPS Plus Abstinence-Contingent Wage Supplement
- First Posted Date
- 2018-05-08
- Last Posted Date
- 2024-06-27
- Lead Sponsor
- Johns Hopkins University
- Target Recruit Count
- 152
- Registration Number
- NCT03519009
- Locations
- πΊπΈ
Center for Learning and Health, Baltimore, Maryland, United States
Membrane Sweeping in Early Labor and Delivery Outcomes
Not Applicable
Withdrawn
- Conditions
- Early Labor
- Interventions
- Procedure: Membrane sweeping
- First Posted Date
- 2018-05-07
- Last Posted Date
- 2020-09-18
- Lead Sponsor
- Johns Hopkins University
- Registration Number
- NCT03517696
- Locations
- πΊπΈ
Johns Hopkins, Baltimore, Maryland, United States
Feasibility of Home Telehealth Monitoring for Improvement in Management of Hypertension for Secondary Stroke Prevention
Not Applicable
Withdrawn
- Conditions
- StrokeHypertension
- Interventions
- Other: Primary Care Physician Management of blood pressureDevice: Withings Smart Blood Pressure Monitor
- First Posted Date
- 2018-05-07
- Last Posted Date
- 2019-05-15
- Lead Sponsor
- Johns Hopkins University
- Registration Number
- NCT03517709
- Locations
- πΊπΈ
Johns Hopkins Hospital, Baltimore, Maryland, United States
Personalized Treatment in Thyroid Disorders
Not Applicable
Recruiting
- Conditions
- Thyroid CancerGraves Disease
- Interventions
- Device: Cervical Collar Therapy Indicator (COTI)
- First Posted Date
- 2018-05-07
- Last Posted Date
- 2024-10-04
- Lead Sponsor
- Johns Hopkins University
- Target Recruit Count
- 10
- Registration Number
- NCT03517579
- Locations
- πΊπΈ
Johns Hopkins Hospital, Baltimore, Maryland, United States
Evolocumab in Acute Coronary Syndrome
- First Posted Date
- 2018-05-03
- Last Posted Date
- 2024-11-15
- Lead Sponsor
- Johns Hopkins University
- Target Recruit Count
- 60
- Registration Number
- NCT03515304
- Locations
- πΊπΈ
Steven Paul Schulman, Baltimore, Maryland, United States
A Pilot Study of mDOT for Immunosuppressant Adherence in Adult Liver Transplant Recipients
Not Applicable
Withdrawn
- Conditions
- Medication AdherenceLiver Transplant
- Interventions
- Other: mHealth Intervention
- First Posted Date
- 2018-05-03
- Last Posted Date
- 2021-09-23
- Lead Sponsor
- Johns Hopkins University
- Registration Number
- NCT03515330
- Locations
- πΊπΈ
Johns Hopkins Hospital, Baltimore, Maryland, United States
Rapid HIV Treatment Initiation, Access and Engagement in Care
Not Applicable
Completed
- Conditions
- Human Immunodeficiency Virus
- Interventions
- Drug: Emtricitabine/Tenofovir Alafenamide 200 MG-25 MG Oral Tablet [DESCOVY]
- First Posted Date
- 2018-05-01
- Last Posted Date
- 2022-10-27
- Lead Sponsor
- Johns Hopkins University
- Target Recruit Count
- 32
- Registration Number
- NCT03512964
- Locations
- πΊπΈ
Johns Hopkins University, Baltimore, Maryland, United States
Β© Copyright 2025. All Rights Reserved by MedPath